UK-based drug giants GlaxoSmithKline and AstraZeneca have linked arms with The University of Manchester under a unique collaboration that has created the Manchester Collaborative Centre for Inflammation Research (MCCIR), a translational centre for inflammatory diseases.
With funding of £5 million from each partner over three years, the project will hook up scientists from the pharmaceutical industry and academia allowing them to work together on inflammation research and translational medicine.
